Pilar Gonzalo

Pilar Gonzalo

Auto-generated profile, based on publicly available information

Pilar Gonzalo

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
VNVanessa Núñez
Vanessa Núñez
DADaniel Alameda
Daniel Alameda
DRDaniel Rico
Daniel Rico
RMRubén A. Mota-Blanco
Rubén A. Mota-Blanco
PGPilar Gonzalo
Pilar Gonzalo
MRMercedes Ricote
Mercedes Ricote
The retinoid X receptor α (RXRα) plays a central role in the regulation of many intracellular receptor signaling pathways and can mediate ligand-dependent transcription by forming homodimers or heterodimers with other nuclear receptors. Although several members of the nuclear hormone receptor superfamily have emerged as important regulators of macrophage gene expression, the existence in vivo of an RXR signaling pathway in macrophages has not been established. Here, we provide evidence that RXRα regulates the transcription of the chemokinesCcl6andCcl9in macrophages independently of heterodimeric partners. Mice lacking RXRα in myeloid cells exhibit reduced levels of CCL6 and CCL9, impaired recruitment of leukocytes to sites of inflammation, and lower susceptibility to sepsis. These studies demonstrate that macrophage RXRα plays key roles in the regulation of innate immunity and represents a potential target for immunotherapy of sepsis.

17 July 2018 in Circulation
Verified
Journal Article
Open access
PDF file
MHMagda R. Hamczyk
Magda R. Hamczyk
RVRicardo Villa-Bellosta
Ricardo Villa-Bellosta
PGPilar Gonzalo
Pilar Gonzalo
MAMaría J. Andrés-Manzano
María J. Andrés-Manzano
PNPaula Nogales
Paula Nogales
VAVicente Andrés
Vicente Andrés
Background: Progerin, an aberrant protein that accumulates with age, causes the rare genetic disease Hutchinson-Gilford progeria syndrome (HGPS). Patients who have HGPS exhibit ubiquitous progerin expression, accelerated aging and atherosclerosis, and die in their early teens, mainly of myocardial infarction or stroke. The mechanisms underlying progerin-induced atherosclerosis remain unexplored, in part, because of the lack of appropriate animal models. Methods: We generated an atherosclerosis-prone model of HGPS by crossing apolipoprotein E–deficient ( Apoe –/– ) mice with Lmna G609G/G609G mice ubiquitously expressing progerin. To induce progerin expression specifically in macrophages or vascular smooth muscle cells (VSMCs), we crossed Apoe –/– Lmna LCS/LCS mice with LysMCre and SM22αCre mice, respectively. Progerin expression was evaluated by polymerase chain reaction and immunofluorescence. Cardiovascular alterations were determined by immunofluorescence and histology in male mice fed normal chow or a high-fat diet. In vivo low-density lipoprotein retention was assessed by intravenous injection of fluorescently labeled human low-density lipoprotein. Cardiac electric defects were evaluated by electrocardiography. Results: Apoe –/– Lmna G609G/G609G mice with ubiquitous progerin expression exhibited a premature aging phenotype that included failure to thrive and shortened survival. In addition, high-fat diet–fed Apoe –/– Lmna G609G/G609G mice developed a severe vascular pathology, including medial VSMC loss and lipid retention, adventitial fibrosis, and accelerated atherosclerosis, thus resembling most aspects of cardiovascular disease observed in patients with HGPS. The same vascular alterations were also observed in Apoe –/– Lmna LCS/LCS SM22αCre mice expressing progerin specifically in VSMCs, but not in Apoe –/– Lmna LCS/LCS LysMCre mice with macrophage-specific progerin expression. Moreover, Apoe –/– Lmna LCS/LCS SM22αCre mice had a shortened lifespan despite the lack of any overt aging phenotype. Aortas of ubiquitously and VSMC-specific progerin-expressing mice exhibited increased retention of fluorescently labeled human low-density lipoprotein, and atheromata in both models showed vulnerable plaque features. Immunohistopathological examination indicated that Apoe –/– Lmna LCS/LCS SM22αCre mice, unlike Apoe –/– Lmna G609G/G609G mice, die of atherosclerosis-related causes. Conclusions: We have generated the first mouse model of progerin-induced atherosclerosis acceleration, and demonstrate that restricting progerin expression to VSMCs is sufficient to accelerate atherosclerosis, trigger plaque vulnerability, and reduce lifespan. Our results identify progerin-induced VSMC death as a major factor triggering atherosclerosis and premature death in HGPS.

1 March 2006 in Cancer and Metastasis Reviews
Verified
Journal Article
Closed access
PDF file
LGLaura Genís
Laura Genís
Beatriz G. GalvezBeatriz G. Galvez
Beatriz G. Galvez
PGPilar Gonzalo
Pilar Gonzalo
AAAlicia G. Arroyo
Alicia G. Arroyo

1 January 2010 in Developmental Cell
Verified
Journal Article
Closed access
PGPilar Gonzalo
Pilar Gonzalo
MGMarta C. Guadamillas
Marta C. Guadamillas
MHMaría Victoria Hernández-Riquer
María Victoria Hernández-Riquer
ÁPÁngela Pollán
Ángela Pollán
AGAraceli Grande-García
Araceli Grande-García
AAAlicia G. Arroyo
Alicia G. Arroyo

12 March 2019 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
MHMagda R. Hamczyk
Magda R. Hamczyk
RVRicardo Villa-Bellosta
Ricardo Villa-Bellosta
VQVíctor Quesada
Víctor Quesada
PGPilar Gonzalo
Pilar Gonzalo
SVSandra Vidak
Sandra Vidak
VAVicente Andrés
Vicente Andrés
Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disorder caused by progerin, a mutant lamin A variant. HGPS patients display accelerated aging and die prematurely, typically from atherosclerosis complications. Recently, we demonstrated that progerin‐driven vascular smooth muscle cell (VSMC) loss accelerates atherosclerosis leading to premature death in apolipoprotein E‐deficient mice. However, the molecular mechanism underlying this process remains unknown. Using a transcriptomic approach, we identify here endoplasmic reticulum stress (ER) and the unfolded protein responses as drivers of VSMC death in two mouse models of HGPS exhibiting ubiquitous and VSMC‐specific progerin expression. This stress pathway was also activated in HGPS patient‐derived cells. Targeting ER stress response with a chemical chaperone delayed medial VSMC loss and inhibited atherosclerosis in both progeria models, and extended lifespan in the VSMC‐specific model. Our results identify a mechanism underlying cardiovascular disease in HGPS that could be targeted in patients. Moreover, these findings may help to understand other vascular diseases associated with VSMC death, and provide insight into aging‐dependent vascular damage related to accumulation of unprocessed toxic forms of lamin A. Synopsis In mouse models of Hutchinson–Gilford progeria syndrome (HGPS) featuring ubiquitous or vascular smooth muscle cell (VSMC)‐specific progerin expression, RNA sequencing of medial aortas identified a new pathway involved in the etiopathology of the disease. Activation of endoplasmic reticulum (ER) stress and of the unfolded protein response (UPR) was observed prior signs of vascular disease in VSMC‐rich aortic media from mouse models of HGPS. ER stress and the UPR were activated in cultured cells derived from HGPS patients and in some organs of the ubiquitous HGPS mouse model. VSMC loss was ameliorated and atherosclerosis was prevented in the HGPS mouse models upon tauroursodeoxycholic acid (TUDCA) treatment. VSMC‐specific progeroid mice survival was prolonged by TUDCA, demonstrating its potential as a treatment for vascular disease in HGPS.

6 August 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
IPIsabel Puig
Isabel Puig
STStephan P. Tenbaum
Stephan P. Tenbaum
ICIrene Chicote
Irene Chicote
OAOriol Arqués
Oriol Arqués
JMJordi Martínez-Quintanilla
Jordi Martínez-Quintanilla
HPHéctor G. Palmer
Héctor G. Palmer
Dormant or slow-cycling tumor cells can form a residual chemoresistant reservoir responsible for relapse in patients, years after curative surgery and adjuvant therapy. We have adapted the pulse-chase expression of H2BeGFP for labeling and isolating slow-cycling cancer cells (SCCCs). SCCCs showed cancer initiation potential and enhanced chemoresistance. Cells at this slow-cycling status presented a distinctive nongenetic and cell-autonomous gene expression profile shared across different tumor types. We identified TET2 epigenetic enzyme as a key factor controlling SCCC numbers, survival, and tumor recurrence. 5-Hydroxymethylcytosine (5hmC), generated by TET2 enzymatic activity, labeled the SCCC genome in carcinomas and was a predictive biomarker of relapse and survival in cancer patients. We have shown the enhanced chemoresistance of SCCCs and revealed 5hmC as a biomarker for their clinical identification and TET2 as a potential drug target for SCCC elimination that could extend patients’ survival.